Adicet Bio (NASDAQ:ACET) Raised to “Hold” at StockNews.com
Adicet Bio (NASDAQ:ACET – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Monday. A number of other research firms have also weighed in on ACET. Guggenheim reiterated a “buy” rating and issued a $7.00 price objective on shares of […]
